L. Douarin, B. Zechel, C. Garnier, J. Lutz, Y. Tora et al., The N-terminal part of TIF1, a putative mediator of the liganddependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18, EMBO J, vol.14, pp.2020-2033, 1995.

S. Thenot, C. Henriquet, H. Rochefort, and V. Cavailles, Differential Interaction of Nuclear Receptors with the Putative Human Transcriptional Coactivator hTIF1, Journal of Biological Chemistry, vol.272, issue.18, pp.12062-12068, 1997.
DOI : 10.1074/jbc.272.18.12062

L. Douarin, B. Nielsen, A. Garnier, J. Ichinose, H. Jeanmougin et al., A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors, EMBO J, vol.15, pp.6701-6715, 1996.

L. Douarin, B. You, J. Nielsen, A. Chambon, P. Losson et al., TIF1??: A possible link between KRAB zinc finger proteins and nuclear receptors, The Journal of Steroid Biochemistry and Molecular Biology, vol.65, issue.1-6, pp.43-50, 1998.
DOI : 10.1016/S0960-0760(97)00175-1

C. Teyssier, C. Ou, K. Khetchoumian, R. Losson, and M. Stallcup, Transcriptional Intermediary Factor 1?? Mediates Physical Interaction and Functional Synergy between the Coactivator-Associated Arginine Methyltransferase 1 and Glucocorticoid Receptor-Interacting Protein 1 Nuclear Receptor Coactivators, Molecular Endocrinology, vol.20, issue.6, pp.1276-1286, 2006.
DOI : 10.1210/me.2005-0393
URL : https://hal.archives-ouvertes.fr/hal-00188164

S. Haynes, C. Dollard, F. Winston, S. Beck, J. Trowsdale et al., and yeast proteins, Nucleic Acids Research, vol.20, issue.10, p.2603, 1992.
DOI : 10.1093/nar/20.10.2603

B. Reddy, L. Etkin, and P. Freemont, A novel zinc finger coiled-coil domain in a family of nuclear proteins, Trends in Biochemical Sciences, vol.17, issue.9, pp.344-345, 1992.
DOI : 10.1016/0968-0004(92)90308-V

S. Klugbauer and H. Rabes, The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas, Oncogene, vol.18, issue.30
DOI : 10.1038/sj.onc.1202824

C. Fan, D. Oh, L. Wessels, B. Weigelt, D. Nuyten et al., Concordance among Gene-Expression???Based Predictors for Breast Cancer, New England Journal of Medicine, vol.355, issue.6, pp.560-569, 2006.
DOI : 10.1056/NEJMoa052933

D. Birnbaum and C. Theillet, Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles, Oncogene, vol.27, pp.5359-5372, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00290484

B. Orsetti, M. Nugoli, N. Cervera, L. Lasorsa, P. Chuchana et al., Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q, British Journal of Cancer, vol.63, issue.10, pp.1439-1447, 2006.
DOI : 10.1158/0008-5472.CAN-04-0474
URL : https://hal.archives-ouvertes.fr/inserm-00157275

H. Soule, J. Vazguez, A. Long, S. Albert, and M. Brennan, A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2, JNCI: Journal of the National Cancer Institute, vol.51, issue.5, pp.1409-1416, 1973.
DOI : 10.1093/jnci/51.5.1409

H. Johnsen, L. Akslen, O. Fluge, A. Pergamenschikov, C. Williams et al., Botstein D: Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000.

J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma et al., A gene-expression signature as a predictor of survival in breast cancer, N Engl J Med, vol.347, pp.1999-2009, 2002.

L. Veer, H. Dai, M. Van-de-vijver, Y. He, A. Hart et al., Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, issue.6871, pp.530-536, 2002.
DOI : 10.1038/415530a

H. Chang, D. Nuyten, J. Sneddon, T. Hastie, R. Tibshirani et al., From The Cover: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival, Proceedings of the National Academy of Sciences, vol.102, issue.10, pp.3738-3743, 2005.
DOI : 10.1073/pnas.0409462102

S. Paik, S. Shak, G. Tang, C. Kim, J. Baker et al., A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer, New England Journal of Medicine, vol.351, issue.27, pp.2817-2826, 2004.
DOI : 10.1056/NEJMoa041588

X. Ma, Z. Wang, P. Ryan, S. Isakoff, A. Barmettler et al., A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen, Cancer Cell, vol.5, issue.6, pp.607-616, 2004.
DOI : 10.1016/j.ccr.2004.05.015

K. Khetchoumian, M. Teletin, J. Tisserand, B. Herquel, K. Ouararhni et al., ): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancer, p.24

D. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally et al., ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform, Neoplasia, vol.6, issue.1, pp.1-6, 2004.
DOI : 10.1016/S1476-5586(04)80047-2

A. Richardson, Z. Wang, D. Nicolo, A. Lu, X. Brown et al., X chromosomal abnormalities in basal-like human breast cancer, Cancer Cell, vol.9, issue.2, pp.121-132, 2006.
DOI : 10.1016/j.ccr.2006.01.013

G. Castoldi and L. Del-senno, Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML, Leukemia, vol.16, pp.886-893, 2002.

J. Strefford, I. Stasevich, T. Lane, Y. Lu, T. Oliver et al., A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma, Cancer Genetics and Cytogenetics, vol.159, issue.1, pp.1-9, 2005.
DOI : 10.1016/j.cancergencyto.2004.09.020

A. Jain and M. Barton, Regulation of p53: TRIM24 enters the RING, Cell Cycle, vol.8, issue.22, pp.3668-3674, 2009.
DOI : 10.4161/cc.8.22.9979